References
Cortese C, Lewis B, Miller NE et al. Myelomatosis with Type III hyperlipoproteinemia: clinical and metabolic studies. N Engl J Med 1982; 307: 79–83.
Feussner G, von Hodenberg E, Ziegler R . Atypical type III hyperlipoproteinemia in a patient with IgA myelomatosis. Klin Wochenschr 1990; 68: 526–532.
Hambrecht R, von Hodenberg E, Schuler G et al. Type III hyperlipoproteinemia in monoclonal IgM gammopathy. Deut Med Wochenschr 1991; 116: 1710–1714.
Spagnuolo V, Motti C, Pujia A et al. Dyslipoproteinemia and monoclonal gammopathy: a case report. Ann Ital Med Intern 1996; 11: 204–207.
Johnston JD, Lumb PJ, Wierzbicki AS . Hyperlipidaemia in association with benign paraproteinaemia. Ann Clin Biochem 1997; 34: 697–699.
Nozaki S, Ito Y, Nakagawa T et al. Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma. Intern Med 1997; 36: 920–925.
Fonseca R, Barlogie B, Bataille R et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546–1558.
Perez-Simon JA, Garcia-Sanz R, Tabernero MD et al. Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes. Blood 1998; 91: 3366–3371.
Acknowledgements
We are grateful to Professor Tony Green for advice on donor management.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chee, L., Spearing, R., Morris, C. et al. Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient. Bone Marrow Transplant 35, 1213–1214 (2005). https://doi.org/10.1038/sj.bmt.1704973
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704973
- Springer Nature Limited
This article is cited by
-
Hyperlipidemic myeloma: review of 53 cases
Annals of Hematology (2010)